Provided by Tiger Trade Technology Pte. Ltd.

Harmony Biosciences Holdings, Inc.

40.28
+0.68001.72%
Post-market: 39.60-0.6790-1.69%18:17 EDT
Volume:487.16K
Turnover:19.60M
Market Cap:2.35B
PE:13.03
High:40.57
Open:39.53
Low:39.51
Close:39.60
52wk High:43.49
52wk Low:25.52
Shares:58.24M
Float Shares:52.10M
Volume Ratio:0.65
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.09
EPS(LYR):2.71
ROE:20.46%
ROA:11.62%
PB:2.35
PE(LYR):14.86

Loading ...

Harmony Biosciences - Reiterates Fy2026 Net Product Revenue Guidance of $1 Bln to $1.04 Bln

THOMSON REUTERS
·
Jul 16

Harmony Biosciences - Announces Preliminary Q2 2026 Wakix Revenue of Approx $261 Mln, up 30% Year over Year

THOMSON REUTERS
·
Jul 16

Harmony Biosciences - Appoints Stephen Mollichella as Interim Principal Financial Officer

THOMSON REUTERS
·
Jul 16

Harmony Biosciences - CFO Glenn Reicin Steps Down Effective July 16, 2026

THOMSON REUTERS
·
Jul 16

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 08

Harmony Biosciences is Maintained at Hold by Deutsche Bank

Dow Jones
·
Jul 01

U.S. Research Roundup- Comcast, Honeywell Aerospace, Qualys

Reuters
·
Jun 30

Analysts Are Bullish on Top Healthcare Stocks: Achieve Life Sciences (ACHV), Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Jun 24

Harmony Biosciences spotlights Phase 3 HBS-301 narcolepsy, idiopathic hypersomnia studies at SLEEP 2026

Reuters
·
Jun 11

Harmony Biosciences to present six narcolepsy, idiopathic hypersomnia posters at SLEEP 2026 meeting

Reuters
·
Jun 11

Looking Back at Stock Picks Hyatt Hotels, Sensient Technologies, Harmony Biosciences. What the Charts Say. -- Barrons.com

Dow Jones
·
Jun 04

Harmony Biosciences to present at Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
May 27

Harmony Biosciences CFO Glenn Reicin files initial beneficial ownership statement

Reuters
·
May 19

Harmony Biosciences Shareholders Approve Governance Measures at Meeting

TIPRANKS
·
May 15

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Maravai Lifesciences Holdings (MRVI) and Alkermes (ALKS)

TIPRANKS
·
May 11

Harmony Biosciences Is Maintained at Hold by Truist Securities

Dow Jones
·
May 09

Harmony Biosciences price target raised to $29 from $25 at Truist

TIPRANKS
·
May 08

Harmony Biosciences backs FY26 revenue view $1B-$1.04B, consensus $1.02B

TIPRANKS
·
May 07

Stock Track | Harmony Biosciences Plunges 5.43% in Pre-Market After Q1 Earnings Miss Estimates

Stock Track
·
May 07

GUIDANCE: (HRMY) Harmony Biosciences Expects 2026 WAKIX Net Revenue Range $1.0B - $1.04B

MT Newswires Live
·
May 07